ALSO NOTED: New constipation data; GSK touts Cervarix study; Spherix transitions to biotech; and much more...

> Wyeth and Progenics say that a three-month extended study of their constipation therapy produced positive data. Release

> GlaxoSmithKline says that the biggest study yet has produced impressive data on the effectiveness of Cervarix in preventing cervical cancer. It will need plenty of powerful data if it intends to grab market share from Gardasil. Release

> Spherix is transitioning to a full-fledged biotech company with the $17 million sale of its subsidiary to Active Network. Report

> StemCells has agreed to a stay on its patent lawsuit with Neuralstem. Report

And Finally... With billions of dollars of revenue on the line, Amgen is asking Congress not to make "precipitate changes" in the way that the government reimburses for anemia drugs. Report